Connect with UsInvestorsCareersMediaScienceContact Us
HomeNewsPfizer Hong Kong Awarded 2009 Hong Kong Management Association Quality Award - Gold AwardPfizer Hong Kong Awarded 2009 Hong Kong Management Association Quality Award - Gold Award



(July 6, 2009) Pfizer Corporation Hong Kong has been awarded 2009 Hong Kong Management Association (HKMA) Quality Award - Gold Award in recognition of the company’s achievements in outstanding management practices.

The HKMA Quality Award is presented annually to the company that has demonstrated commitment to the process of quality management and achieved excellent standards of quality. The award is based on seven criteria: leadership, strategic planning, customer and market focus, workforce focus, process management, measurement, analysis and knowledge management, as well as results.

As the recipient of this award, Pfizer has excelled in the following areas:

Colleagues exhibiting leadership behavior
Outstanding financial results and proven track record
Workforce-focused culture
Commitment to mission - adding value to colleagues and customers
Business technology advancement and process management
Long term strategic planning to meet market needs
Recognition as an innovator in the industry

"It is our honor to be the winner of the 2009 HKMA Quality Award - Gold Award," said Mr. Stephen Leung, Country Manager of Pfizer Hong Kong. "I am so proud that our colleagues’ contributions in providing quality services and products has been recognized. This award will encourage us to continue our pursuit of excellence in every aspect of management and deliver quality services. We hope that by winning this award we can raise public awareness of healthcare excellence to make Hong Kong a better place to live and work."

The award was presented at the 2009 HKMA Quality Award Dinner on Monday, July 6, 2009 at the Inter-Continental Hotel in Hong Kong.

About the Award

The Quality Award was first launched in 1991 by the Hong Kong Management Association. With this annual award, the association seeks not just to reward, but also bring public recognition to those organizations that have achieved outstanding standards of quality and made a lasting commitment to the process of quality management.

About Pfizer Hong Kong

Pfizer Hong Kong, a subsidiary of Pfizer Inc, was established in 1956 and is responsible for the sales, distribution and promotion of Pfizer products in Hong Kong and Macau. Pfizer Hong Kong is committed to adding value to our colleagues and customers with the aim of improving the quality of life for the Hong Kong people.

Pfizer has been recognized on numerous occasions as an innovator and a pacesetter in the industry. In addition to our outstanding financial results, Pfizer has received awards in the areas of workplace planning, leadership and human resources, corporate wellness, and community services.

  • "Human Resources Leadership Award" by the World HRD Congress in Mumbai (2009)

  • "Outstanding Brand Award - Western Medicine" by the Economic Digest (Lipitor, 2008; Viagra, 2009)

  • "Caring Company" by the Hong Kong Council of Social Service (2002-2008)

  • "People Management Award" by the Hong Kong Institute of Human Resources Management/South China Morning Post (2006)

  • "Gold Award for Volunteer Services" by the Social Welfare Department (2004)

  • "Smoke-Free Workplace Leading Company Award" by the Hong Kong Council on Smoking and Health and RTHK (2004)

  • "Superbrand Hong Kong" (2002-2003)

Careers News Useful LinksHealthcare ProfessionalUseful LinksPrivacy PolicyTerms of UseConnect with Us Privacy statement Terms of Use Distributors Grant Seekers Media Copyright © 2023 Pfizer Corporate Hong Kong Limited.  All right reserved. The product information provided in this site is intended only for healthcare professionals who reside of Hong Kong, and the products discussed herein may have different product labeling in different countries/regions.  Pfizer Corporate Hong Kong Limited is a pharmaceutical company committed to helping people improve their health by discovering and developing medicines.